Table 2 MMR gene mutations in rapid autopsy patients.
From: Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
Autopsy patient* | Tumour site(s) tested by BROCA targeted sequencing | Mutation burden †(exome) | Hypermutated? | MSI | MMR gene mutation(s) ‡ |
---|---|---|---|---|---|
05–165* | Bone, adrenal, liver and lymph node | 855 | Yes | Yes | (1) MSH2-C2orf61 343 kb inversion |
 |  |  |  |  | (2) MSH2-KCNK12 74 kb inversion |
 |  |  |  |  | (3) MSH2-KCNK12 40 kb inversion |
03–130 | Lymph node | 647 | Yes | Yes | (1) MSH2 translocation splits the gene t(2;18) |
 |  |  |  |  | (2) MSH2 copy loss |
 |  |  |  |  | (3) MSH6 frameshift (c.2690del) |
 |  |  |  |  | (4) MSH6 copy loss |
06–134 | Kidney and lymph node | 314 | Yes | Yes | MLH1 homozygous copy loss |
00–010 | Prostate and liver | 673 | Yes | Yes | MSH2 frameshift (c.2364_2365insTACA) |
05–123 | Prostate and lymph node | 807 | Yes | Yes | (1) MSH2 frameshift (c.1124_1125insG) |
 |  |  |  |  | (2) MSH2 frameshift (c.1082del) |
 |  |  |  |  | (3) MLH1 frameshift (c.1310del), lymph node only |
01–095 | Liver and lymph node | 149 | No | No | None |
05–144* | Bone, adrenal, liver and lymph node | 57 | No | No | (1) MSH2 exon 8–16 del |
 |  |  |  |  | (2) MSH6-TESC t(2;12) |
05–214 | Bone, liver and lymph node (two sites) | 46 | No | No | None |
05–116 | Bone, adrenal, liver and lung | 47 | No | No | None |
00–029 | Liver | 37 | No | No | None |
00–090 | Lymph node | 69 | No | No | None |